Incyte INCY
NASDAQ INCY
$117.14 -4.21 (-3.47%)
At close: Oct 1, 2026 · 4:00 PM EDT

Incyte (INCY) Interest Expenses (2010 - 2026)

Updated

Incyte (INCY) posted Interest Expenses of $582,000 for Q2 2026, down 2.0% from $594,000 a year earlier but up 2.3% from the prior quarter.

Analysis

Incyte (INCY) Interest Expenses (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Interest Expenses at Incyte was $2.33 million, down 5.0% year-over-year; for FY2025, it came in at $2.43 million, up 6.5% from FY2024.

  • Annual Interest Expenses shows a five-year compound annual growth rate of 2.2% (FY2020 to FY2025).
  • In prior years, Incyte's Interest Expenses was $2.28 million in FY2024 (-10.6%), $2.55 million in FY2023 (-4.3%), $2.67 million in FY2022 (+39.7%) and $1.91 million in FY2021 (-12.2%).
  • Quarterly Interest Expenses has run from a low of $419,000 in Q4 2024 to a high of $804,000 in Q4 2023 over five years.
  • On a year-over-year basis, Interest Expenses increased in three of the last eight quarters, with growth averaging 2.5%.
  • The strongest year-over-year quarter for Interest Expenses in the past five years was Q1 2022, with growth of 89.4%; the weakest was Q4 2024, with a decline of 47.9%.
  • According to Business Quant data, Interest Expenses for the three prior quarters was $569,000 (Q1 2026), $582,000 (Q4 2025) and $592,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Incyte 24.39 Bn 9.33 Bn 1.57 Bn 582,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 582,000.00
Mar 31, 2026 569,000.00
Dec 31, 2025 582,000.00
Sep 30, 2025 592,000.00
Jun 30, 2025 594,000.00
Mar 31, 2025 660,000.00
Dec 31, 2024 419,000.00
Sep 30, 2024 774,000.00
Jun 30, 2024 657,000.00
Mar 31, 2024 430,000.00
Dec 31, 2023 804,000.00
Sep 30, 2023 623,000.00
Jun 30, 2023 655,000.00
Mar 31, 2023 469,000.00
Dec 31, 2022 667,000.00
Sep 30, 2022 641,000.00
Jun 30, 2022 678,000.00
Mar 31, 2022 680,000.00
Dec 31, 2021 752,000.00
Sep 30, 2021 439,000.00
API Access

Incyte Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=INCY&period=max&api_key=YOUR_API_KEY